image_pdfimage_print

Author Archives: hksar gov

First batch of new drugs approved by “1+” mechanism listed on HA Drug Formulary

The following is issued on behalf of the Hospital Authority:

     The Hospital Authority (HA) announced today (July 26) that the two new drugs for treating cancer, approved for registration in Hong Kong after review under the new mechanism for registration of New Drugs (“1+” mechanism), are listed under the category of “Special Drug” on the HA Drug Formulary (HADF). The new drugs are the oral targeted therapy for treating metastatic colorectal cancer and are suitable for patients for whom conventional chemotherapy has been ineffective or inapplicable. Patients prescribed with these new drugs under specified clinical application are only required to pay for the standard fees and charges, which are substantially subsidised. This could greatly alleviate the financial burden on patients. It is estimated that around 300 patients will benefit every year and the subsidy amount is around $12 million.

     “With the ‘1+’ mechanism now in effect, the number of drugs successfully registered in Hong Kong would increase, thus enabling clinicians and patients to have more choices for drug treatment. The HA is conducting a comprehensive review of the procedure of new drugs listing on the HADF with the aim of expediting the process. While bringing new hope for the treatment of life-threatening or severely debilitating diseases, we hope that the financial burden on patients could also be greatly alleviated,” the Chief Pharmacist of the HA, Mr William Chui, said.

     Apart from the two drugs aforementioned, the HA is actively proceeding with the listing of a third new registered drug, which is for treating paroxysmal nocturnal hemoglobinuria, on the HADF. The procedure is expected to be completed in the coming few months.

     The HA will continue to meet regularly with patient groups and other stakeholders to receive their opinions and suggestions on the listing of new drugs. The HA will also boost efforts in patient empowerment to ensure patients are well-informed about the relevant drug information. The HA will continue to enhance evaluation of new drugs as well as reviews of the HADF and the coverage of the safety net, so that more treatment options will be available for patients. The HA will also consult experts on health economics to have more cost-effective drugs of proven safety and efficacy listed on the HADF, benefitting more patients. read more

Two qualified persons and their authorized signatories prohibited by disciplinary board from certifying prescribed inspection and repair of windows for a period ranging from six months to permanently

     The Registered Contractors’ Disciplinary Board has completed three disciplinary inquiries under the Buildings Ordinance (BO) and decided that two Registered Minor Works Contractors (RMWC) appointed as qualified persons (QP) under the Mandatory Window Inspection Scheme (MWIS) and their Authorized Signatories (AS) should be disciplined for failing to discharge the duties or abide by the requirements imposed on a QP under the BO.
 
     The Board’s written decisions and orders issued on July 10 were published in the Gazette today (July 26). Details are available at the following links:
 
For the first and the second cases: www.gld.gov.hk/egazette/pdf/20242830/egn202428304278.pdf
For the third case: www.gld.gov.hk/egazette/pdf/20242830/egn202428304279.pdf
 
     The first and the second cases involve the same RMWC and its AS.
 
     In the first case concerning a domestic flat in Ma On Shan, the RMWC and its AS submitted a certificate to the Buildings Department (BD) in July 2016, certifying that prescribed inspection and prescribed repair had been carried out to the windows of the flat. Subsequently, the BD carried out an investigation in response to a report from the owner and found that the prescribed inspection was not carried out personally by the RMWC and its AS.
 
     The RMWC and its AS were later prosecuted, convicted and fined $15,000 in total at the Shatin Magistrates’ Courts in July 2019, pursuant to sections 40(2A)(c) and 40(2AD) of the BO, for knowingly misrepresenting a material fact in the certificate submitted to the BD and failing to carry out the prescribed inspection personally.
 
     In the second case concerning a domestic flat in Wan Chai, the same RMWC and its AS submitted a certificate to the BD in June 2018, certifying that prescribed inspection had been carried out to the windows of the flat and that those windows were safe and no prescribed repair was required. Subsequently, the BD carried out an investigation in response to an emergency report of a fallen window from the flat concerned and found that rivets of some windows of the units were broken, missing or corroded. Based on the investigation findings and having consulted the Department of Justice, the BD did not instigate prosecution action against the RMWC and the AS due to insufficient evidence.
 
     In the third case, another RMWC and its AS submitted a certificate to the BD in December 2019, certifying that a prescribed inspection had been carried out to the windows of a domestic flat in Yau Ma Tei, and that those windows were safe and no prescribed repair was required. Subsequently, the BD conducted an audit inspection and found that signs of deterioration or defective window components were identified in some of the windows. Further investigation also revealed that the RMWC had failed to carry out the prescribed inspection for all the windows of the flat.
 
     The RMWC and its AS were later prosecuted, convicted and fined $16,000 in total at the Kwun Tong Magistrates’ Courts in July 2021, pursuant to sections 40(2A)(c) and 40(2B)(b) of the BO, for knowingly misrepresenting a material fact in the certificate submitted to the BD and carrying out prescribed inspection in a manner likely to cause a risk of personal injury or property damage.
 
     In view of the convictions or investigation results, the BD notified the Board for its consideration of disciplinary action against the two RMWC and their AS under the provisions of section 13(1) of the BO.
 
     In the first case, the Board ordered the RMWC and its AS to be prohibited from certifying any prescribed inspection, or certifying or supervising any prescribed repair of windows, for eight months with effect from the date of the Gazette, and to pay a total of $43,200, being the costs of the Board and the BD for conducting the inquiry.
 
     In the second case, the Board ordered the RMWC to be prohibited from certifying any prescribed inspection, or certifying or supervising any prescribed repair of windows for 24 months with effect from the date of the Gazette, and the AS to be permanently prohibited from certifying any prescribed inspection, or certifying or supervising any prescribed repair of windows, both penalties to run concurrently with the order of the first case above. This is the first time the Board has ordered an AS to be permanently prohibited from certifying prescribed inspection and repair of windows. Furthermore, the RMWC and its AS have to pay a total of $38,800, being the costs of the Board and the BD for conducting the inquiry
 
     In the third case, the Board ordered the RMWC and its AS to be prohibited from certifying any prescribed inspection, or certifying or supervising any prescribed repair of windows, for six months with effect from the date of the Gazette, and to pay a total of $42,100, being the costs of the Board and the BD for conducting the inquiry.
 
     A spokesperson for the BD reiterated that in order to ensure building safety, the BD attaches great importance to the quality of the prescribed inspection and repair of windows by a QP under the MWIS. Any QP who contravenes the relevant provisions of the BO in carrying out the prescribed inspection and repair of windows under the MWIS is not only liable to criminal prosecution but also disciplinary action under the BO.
 
     The BD will continue to conduct audit inspections to ensure the quality of prescribed inspections and repairs under the MWIS, he added. read more

Reappointment of Hong Kong Productivity Council Chairman

     â€‹The Government today (July 26) announced that the Chief Executive had reappointed Mr Sunny Tan as the Chairman of the Hong Kong Productivity Council (HKPC) for a two-year term starting from August 6, 2024.
 
     The Secretary for Innovation, Technology and Industry, Professor Sun Dong, welcomed the reappointment of Mr Tan as Chairman of the HKPC. “Under Mr Tan’s able leadership in the past two years, the HKPC has been making valuable and significant contributions to support the Government’s policy in driving ‘new-industrialisation’ in Hong Kong, enhance the competitiveness of Hong Kong’s manufacturing industry with innovation and technology (I&T), and assist enterprises to adopt new technologies to upgrade to high value-added production. I look forward to continuing to work closely with Mr Tan to promote Hong Kong’s I&T and new industrialisation development, and nurture more I&T talent,” Professor Sun said.
 
     Mr Sunny Tan was first appointed as the Chairman of the HKPC in August 2022.
 
     The HKPC was established in 1967 to promote productivity excellence in Hong Kong through providing integrated support to innovative and growth-oriented Hong Kong enterprises across the value chain. The HKPC’s main sectoral focus is Hong Kong’s manufacturing and related service industries, with the main geographical focuses in Hong Kong and the Greater Bay Area. The HKPC provides its clients with a diverse range of supporting services in product development, consultancy, training and technology transfer.
 
     The membership of the Council with effect from August 6, 2024, is as follows:
 
Non-Official Members:
Mr Sunny Tan (Chairman)
Mr Emil Yu Chen-on (Deputy Chairman)
Professor Viveca Chan E-nam
Mr Bryant Chan Wan-sing
Ms Clara Chan Yuen-shan
Mr Brian Cheng Ho-wai
Ms Lily Ching Ngon-lai
Mr Marvin Hsu Tsun-fai
Mr Geoffrey Edward Kao
Mr Anthony Lam Sai-ho
Ms Vivien Lau Man-yee
Professor Matthew Lee Kwok-on
Mr Bernard Poon Che-wai
Ms Jenny Tam Kam-lin
Ms Frankie Tam Wing-see
Mr Donald Tong Chi-keung
Ms Jennifer Yeung Yin-chi
Ms Zhang Li
 
Official Members:
Permanent Secretary for Innovation, Technology and Industry
Commissioner for Innovation and Technology
Director-General of Trade and Industry
Government Economist
Deputy Commissioner for Labour read more